PureTech Health plc (PRTC)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

PureTech Health plc (PRTC) is up 4.7% since the beginning of the year. At $17 per share, PRTC is trading 12.6% below its 52-week high of $20. Investors who bought $1,000 worth of PRTC shares 5 years ago would now be looking at an investment worth $306.

PureTech Health plc (PRTC) has returned 4.69% so far this year and -7.54% over the past 12 months.

Based on dividend-adjusted daily data since Nov 16, 2020, PRTC's average daily return is +0.02%, while the average monthly return is -0.42%.

Historically, 46% of months were positive and 54% were negative. The best month was Dec 2023 with a return of +41.3%, while the worst month was Jun 2024 at -24.2%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 4 months.

On a daily basis, PRTC closed higher 36% of trading days. The best single day was Dec 22, 2023 with a return of +33.9%, while the worst single day was Oct 7, 2022 at -24.2%.

PureTech Health plc has an annualized alpha of -3.44%, beta of 0.51, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since November 17, 2020.

• This stock participated in 163.48% of S&P 500 Index downside but only 52.04% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.51 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PRTC ranks 33 for risk / return — below 33% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for PureTech Health plc (PRTC) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the PureTech Health plc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the PureTech Health plc was 78.91%, occurring on Apr 10, 2025. The portfolio has not yet recovered.

The current PureTech Health plc drawdown is 72.78%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of PureTech Health plc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how PureTech Health plc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.